These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 21556564)

  • 1. Deregulation of tyrosine kinases in a rat macrophage tumor - ectopic expression of lck.
    Sridhar T; Rema V; Swarup G; Khar A
    Int J Oncol; 1995 Feb; 6(2):487-92. PubMed ID: 21556564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage-specific control of superantigen-induced cell death by the protein tyrosine kinase p56(lck).
    Penninger JM; Wallace VA; Molina T; Mak TW
    J Immunol; 1996 Dec; 157(12):5359-66. PubMed ID: 8955183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues.
    Campbell KS; Giorda R
    Eur J Immunol; 1997 Jan; 27(1):72-7. PubMed ID: 9022000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells.
    Biondi A; Paganin C; Rossi V; Benvestito S; Perlmutter RM; Mantovani A; Allavena P
    Eur J Immunol; 1991 Mar; 21(3):843-6. PubMed ID: 1826268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
    Nel AE; Hanekom C; Hultin L
    J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
    Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
    Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
    Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
    Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between CD45 and lck does not require CD4 or CD8 and is independent of T cell receptor stimulation.
    Ross SE; Schraven B; Goldman FD; Crabtree J; Koretzky GA
    Biochem Biophys Res Commun; 1994 Jan; 198(1):88-96. PubMed ID: 8292053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase participates in p56(lck)/CD4-dependent down-regulation of LFA-1-mediated T cell adhesion.
    Mazerolles F; Barbat C; Hivroz C; Fischer A
    J Immunol; 1996 Dec; 157(11):4844-54. PubMed ID: 8943387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression.
    Samraj AK; Stroh C; Fischer U; Schulze-Osthoff K
    Oncogene; 2006 Jan; 25(2):186-97. PubMed ID: 16116473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines.
    Mayer K; Ballhausen WG
    Anticancer Res; 1996; 16(4A):1733-7. PubMed ID: 8712692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
    Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of splice variants of the human ADAM15 gene and strong interaction between the cytoplasmic domain of one variant and Src family proteins Lck and Hck.
    Yasui A; Matsuura K; Shimizu E; Hijiya N; Higuchi Y; Yamamoto S
    Pathobiology; 2004; 71(4):185-92. PubMed ID: 15263807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and expression of lck transcripts in human lymphoid cells.
    Perlmutter RM; Marth JD; Lewis DB; Peet R; Ziegler SF; Wilson CB
    J Cell Biochem; 1988 Oct; 38(2):117-26. PubMed ID: 3265417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels.
    al-Ramadi BK; Nakamura T; Leitenberg D; Bothwell AL
    J Immunol; 1996 Dec; 157(11):4751-61. PubMed ID: 8943376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.